Advanced Biomed Inc (ADVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,657 | 0 | N/A | 0 | N/A |
| TOTAL | $3,139 | $0 | $N/A | $0 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 401 | N/A | N/A | N/A | N/A |
| Intangibles | 51 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 914 | 0 | 0 | 0 | 0 |
| TOTAL | $1,365 | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $4,504 | $0 | $N/A | $0 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,595 | 0 | 0 | 0 | 0 |
| TOTAL | $3,829 | $0 | $N/A | $0 | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 56 | 0 | 0 | 0 | 0 |
| TOTAL | $56 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $3,885 | $0 | $N/A | $0 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,082 | N/A | N/A | N/A | N/A |
| Common Shares | 20 | 0 | N/A | 0 | N/A |
| Retained earnings | -17,148 | 0 | N/A | 0 | N/A |
| Other shareholders' equity | 1,253 | 0 | 0 | 0 | 0 |
| TOTAL | $619 | $0 | $N/A | $0 | $N/A |
| Total Liabilities And Equity | $4,504 | $0 | $0 | $0 | $0 |